Early F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab

Autor: Chen, Aiping, Mokrane, Fatima-Zohra, Schwartz, Lawrence, Morschhauser, Franck, Stamatoullas, Apasia, Schiano de Colella, Jean-Marc, Vercellino, Laetitia, Casasnovas, Olivier, Chauchet, Adrien, Delmer, Alain, Nicolas-Virelizier, Emmanuelle, Ghesquières, Hervé, Moles-Moreau, Marie-Pierre, Schmitt, Anna, Dulery, Rémy, Bouabdallah, Krimo, Borel, Cécile, Touati, Mohamed, Deau-Fischer, Benedicte, Peyrade, Frédéric, Seban, Romain-David, Manson, Guillaume, Armand, Philippe, Houot, Roch, Dercle, Laurent

Publikováno v: Journal of Nuclear Medicine
Journal of Nuclear Medicine, 2020, 61 (5), pp.649-654. ⟨10.2967/jnumed.119.232827⟩
Journal of Nuclear Medicine, Society of Nuclear Medicine, 2020, 61 (5), pp.649-654. ⟨10.2967/jnumed.119.232827⟩

International audience; Monoclonal antibodies (mAbs) against programmed cell death 1 (PD-1), such as nivolumab and pembrolizumab, are associated with high response rates in patients with relapsed or refractory classic Hodgkin lymphoma (HL). To date,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::91e6935b49df966feb65af56185e991e
https://univ-rennes.hal.science/hal-02364994

Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study

Autor: Julien Viotti, Flavia Salvi, Waldemar Kulikowski, M.J. Ouvrier, Edyta Subocz, Simonetta Viviani, Maria Canepari, Andrea Gallamini, Maria Cantonetti, Marc Ettaiche, Silvia Bolis, Livio Trentin, Colette Zwarthoed, Luigi Rigacci, T.C. El-Galaly, Stefano Luminari, Bogdan Małkowski, Anna Borra, Jan Maciej Zaucha, Joanna Tajer, Chiara Rusconi, Jacques Darcourt

Publikováno v: Zwarthoed, C, El-Galaly, T C, Canepari, M, Ouvrier, M J, Viotti, J, Ettaiche, M, Viviani, S, Rigacci, L, Trentin, L, Rusconi, C, Luminari, S, Cantonetti, M, Bolis, S, Borra, A, Darcourt, J, Salvi, F, Subocz, E, Tajer, J, Kulikowski, W, Malkowski, B, Zaucha, J M & Gallamini, A 2017, ' Prognostic value of bone marrow tracer uptake pattern in baseline PET scan in Hodgkin Lymphoma : results from an International Collaborative Study ', Journal of Nuclear Medicine, vol. 58, no. 8, pp. 1249-1254 . https://doi.org/10.2967/jnumed.116.184218

RATIONALE: Positron Emission Tomography/Computed Tomography (PET/CT)-ascertained bone marrow involvement (BMI) constitutes the single most important reason for upstaging by PET/CT in Hodgkin lymphoma (HL). However, BMI assessment in PET/CT can be cha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cfda58a429e6582d17e3088923450fd
https://doi.org/10.2967/jnumed.116.184218

Canine Lymphoma as a Surrogate for Human Lymphomas: What Can We Learn from Canine Clinical Trials?

Autor: Marconato L

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4094::d526bf5e221d27eea3d5d2aa14476164
http://hdl.handle.net/11585/704064

Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients

Autor: Anne-Ségolène Cottereau, Michel Meignan, Lars Jelstrup Petersen, Hervé Tilly, Martin Hutchings, Stéphanie Becker, John O. Prior, Tarec Christoffer El-Galaly, Christophe Bonnet, Florence Broussais, Olivier Casasnovas

Publikováno v: ResearcherID
Journal of Nuclear Medicine
Journal of Nuclear Medicine, Society of Nuclear Medicine, 2018, 59 (4), pp.589-595. ⟨10.2967/jnumed.117.193946⟩
Cottereau, A-S, El-Galaly, T C, Becker, S, Broussais, F, Peterson, L J, Bonnet, C, Prior, J O, Tilly, H, Hutchings, M, Casasnovas, O & Meignan, M A 2018, ' Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients ', Journal of Nuclear Medicine, vol. 59, no. 4, pp. 589-595 . https://doi.org/10.2967/jnumed.117.193946

Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive non-Hodgkin lymphomas with poor outcomes on current therapy. We investigated whether response assessed with PET/CT combined with baseline total metabolic tumor volume (TMTV) cou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c88a9f2da6e70b1890890f0854cde34b
http://jnm.snmjournals.org/content/early/2017/08/31/jnumed.117.193946.abstract

Automated segmentation of TMTV in DLBCL patients: what about method measurement uncertainty?

Autor: Laffon E; CHU de Bordeaux, F-33000 Bordeaux, France, France., Marthan R; CHU de Bordeaux, F-33000 Bordeaux, France, France.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2020 Oct 09. Date of Electronic Publication: 2020 Oct 09.